The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care
NCT ID: NCT05752383
Last Updated: 2023-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2023-01-24
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This observational study is based on clinical, biological, and hemodynamic data recorded during the ICU stay of patients for cardiogenic shock.
The primary endpoint is the relationship between the hemodynamic evolution of cardiogenic shock and in-hospital mortality.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Hemodynamic Assessment in Shocked Patients in the Pediatric Intensive Care Unit
NCT06720493
Scoring Model for Predicting Outcome in Patients With Cardiogenic Shock
NCT04850248
Focus Cardiac Ultrasound in Patients With Shock
NCT04028297
Acute Heart Failure Study in Patients Admitted to Emergency Department for Dyspnea
NCT02835963
Use of Ultrasound in the Initial Management of Patients in Shock in the Nancy Emergency Department
NCT06573541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Picardie
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2022_843_0132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.